Showing results (451-460 of 705) with videos related to

Sort By:
Pageof 71
Brain Research|December 2, 1985
Characterization and autoradiographic distribution of neurotensin binding sites in the human brainA Sarrieau, F Javoy-Agid, P Kitabgi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 20, 2023
Thioarylation of 6-Amino-2,3,6-trideoxy-d-manno-oct-2-ulosonic Acid (IminoKdo): Access to 3,6-Disubstituted Picolinates and Mechanistic InsightsSujit Manmode, Nazar Hussain, Oscar Javier Gamboa Marin, et al.
Bioorganic & Medicinal Chemistry|July 1, 2022
Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacementJian Fu, Ziyao He, Huixiao Fu, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 1, 1997
Normal gastric histology in Helicobacter pylori-infected childrenF Gottrand, F Cullu, D Turck, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2019
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineElaine Gray, Steve Kitchen, Annette Bowyer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 22, 2021
Atlas-based methods for efficient characterization of patient-specific ventricular activation patternsKevin P Vincent, Nickolas Forsch, Sachin Govil, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Are there physical, technical and morphological limits to conformational radiotherapy?]R Garcia, R Oozeer, H Le Thanh, et al.
La Revue De Medecine Interne|January 1, 1996
[Prostacyclin in the treatment of hemolytic-uremic syndrome: apropos of a case]C Series, C Level, S Guez, et al.
British Journal of Haematology|February 14, 2002
Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assayAnne F Riddell, P Vincent Jenkins, Ioana C Nitu-Whalley, et al.
Annals of Clinical Biochemistry|February 16, 2008
Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intakeCarel W le Roux, Cynthia M Borg, Kevin G Murphy, et al.
Pageof 71